Skip to main content
Quest Diagnostics

Optimal Identification of Allergic Sensitization Toward Seasonal Inhalant Allergens in the United States

ACAAI 2023

American College of Allergy, Asthma & Immunology

Anaheim, CA Nov 9-13, 2023

Oral presentation: Optimal Identification of Allergic Sensitization Toward Seasonal Inhalant Allergens in the United States

Authors: Kwong K, Chen Z, Scott L, Hillborne L

Specialty: Infectious disease

Related content

On-Demand Webinar
Interpretation of Respiratory Allergy Results for Patient Management
On-Demand Webinar
The Nuts and Bolts of Food Allergy Component Testing
On-Demand Webinar
Is it an Environmental Allergy? The Role of Serum IgE Testing in the Primary Care and Pediatric Setting
Conference Presentation
Coinfection Rates of SARS-CoV-2, Influenza, and Respiratory Syncytial Virus

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.